Sam-A Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6,580	9,551	9,019	9,176	7,984
Short-Term Investments	39,602	48,638	61,638	68,638	45,638
Trading Asset Securities	51,460	18,474	8,447	3,197	-
Cash & Short-Term Investments	97,642	76,664	79,104	81,011	53,623
Cash Growth	27.36%	-3.08%	-2.35%	51.08%	-16.68%
Accounts Receivable	19,468	19,060	22,596	21,466	18,039
Other Receivables	2,081	2,794	3,079	2,025	1,293
Receivables	21,548	21,854	25,675	23,491	19,332
Inventory	16,468	14,283	13,013	12,244	9,341
Prepaid Expenses	207.19	135.22	160.76	71.14	44.88
Other Current Assets	2.96	153.46	38.37	40.27	13.96
Total Current Assets	135,869	113,089	117,992	116,856	82,355
Property, Plant & Equipment	39,173	42,750	40,511	37,164	40,188
Long-Term Investments	50,141	71,939	61,362	42,957	60,434
Other Intangible Assets	4,641	4,189	4,295	4,394	5,537
Long-Term Deferred Tax Assets	420.53	519.39	80.27	1,041	-
Other Long-Term Assets	6,938	6,819	7,067	786.49	657.77
Total Assets	247,045	248,734	231,308	203,198	189,172
Accounts Payable	4,178	5,830	5,002	7,040	3,772
Accrued Expenses	1,360	907.14	2,229	1,745	15.74
Current Portion of Long-Term Debt	2,278	4,556	1,667	-	2,407
Current Portion of Leases	1,820	1,835	1,858	1,725	1,709
Current Income Taxes Payable	233.33	3,721	3,542	4,386	1,580
Other Current Liabilities	4,022	3,659	6,847	6,662	5,111
Total Current Liabilities	13,891	20,508	21,145	21,558	14,594
Long-Term Debt	-	2,278	2,500	-	-
Long-Term Leases	2,844	4,221	5,645	45	1,509
Pension & Post-Retirement Benefits	43.42	82.87	-	-	-
Long-Term Deferred Tax Liabilities	-	18.24	12.05	12.05	175.08
Other Long-Term Liabilities	2,155	1,650	1,536	964.81	868.76
Total Liabilities	18,934	28,758	30,838	22,580	17,147
Common Stock	6,370	6,370	6,370	6,370	6,370
Additional Paid-In Capital	14,413	14,413	14,413	14,413	14,413
Retained Earnings	204,168	196,482	179,204	160,354	149,836
Treasury Stock	-1,513	-1,513	-1,513	-1,513	-1,513
Comprehensive Income & Other	4,673	4,223	1,996	992.92	2,917
Shareholders' Equity	228,111	219,976	200,470	180,618	172,024
Total Liabilities & Equity	247,045	248,734	231,308	203,198	189,172
Total Debt	6,942	12,890	11,669	1,770	5,625
Net Cash (Debt)	90,700	63,774	67,435	79,241	47,998
Net Cash Growth	42.22%	-5.43%	-14.90%	65.09%	-16.01%
Net Cash Per Share	14859.86	10450.12	11048.85	12983.19	7864.24
Filing Date Shares Outstanding	6.1	6.1	6.1	6.1	6.1
Total Common Shares Outstanding	6.1	6.1	6.1	6.1	6.1
Working Capital	121,977	92,581	96,848	95,298	67,761
Book Value Per Share	37366.33	36041.86	32845.97	29593.28	28185.26
Tangible Book Value	223,470	215,787	196,175	176,224	166,488
Tangible Book Value Per Share	36606.16	35355.57	32142.19	28873.32	27278.10
Land	4,346	4,346	4,346	9,343	9,343
Buildings	30,472	30,472	30,472	30,445	30,445
Machinery	30,703	29,435	24,791	23,856	24,141
Construction In Progress	389.96	1,836	1,174	45.73	4.03

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.